T-type calcium channel
CA 2340586 A1 · Owner: South Alabama Medical Science Foundation · Inventors: Li, Ming
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention is directed to isolated nucleic acid molecules encoding pancreatic T-type calcium channels and vectors and host cells comprising such. The invention is further directed to methods and compositions which modulate the expression of pancreatic T-type calcium channels including antisense. An , isolated pancreatic T-type calcium channel protein is provided as well as , antibodies directed to such protein. Pharmaceutical compositions and methods of treatment involving pancreatic T-type calcium channels are also provided.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 26, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 26, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 26, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.